Immunology of Alveolar and Cystic Echinococcosis (AE and CE)

被引:120
作者
Gottstein, B. [1 ]
Soboslay, P. [2 ]
Ortona, E. [3 ]
Wang, J. [1 ]
Siracusano, A. [3 ]
Vuitton, D. A. [4 ]
机构
[1] Univ Bern, Bern, Switzerland
[2] Univ Tubingen, Tubingen, Germany
[3] Ist Super Sanita, Rome, Italy
[4] Univ Franche Comte, WHO Collaborating Ctr, Besancon, France
来源
ECHINOCOCCUS AND ECHINOCOCCOSIS, PT B | 2017年 / 96卷
关键词
BLOOD MONONUCLEAR-CELLS; GRANULOSUS ANTIGEN-B; CELLULAR IMMUNE-RESPONSE; EG95 HYDATID VACCINE; GROWTH-FACTOR-BETA; IN-VIVO TREATMENT; MULTILOCULARIS INFECTION; CYTOKINE PROFILE; LAMINATED-LAYER; LIVER-TRANSPLANTATION;
D O I
10.1016/bs.apar.2016.09.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Cystic and alveolar echinococcosis are severe chronic helminthic diseases caused by the cystic growth or the intrahepatic tumour-like growth of the metacestode of Echinococcus granulosus or Echinococcus multilocularis, respectively. Both parasites have evolved sophisticated strategies to escape host immune responses, mainly by manipulating and directing this immune response towards anergy and/or tolerance. Recent research studies have revealed a number of respective immunoregulatory mechanisms related to macrophages and dendritic cell as well as T cell activities (regulatory T cells, Tregs). A better understanding of this complex parasite-host relationship, and the elucidation of specific crucial events that lead to disease, represents targets towards the development of novel treatment strategies and options.
引用
收藏
页码:1 / 54
页数:54
相关论文
共 204 条
[1]   A parasitic helminth-derived peptide that targets the macrophage lysosome is a novel therapeutic option for autoimmune disease [J].
Alvarado, Raquel ;
O'Brien, Bronwyn ;
Tanaka, Akane ;
Dalton, John P. ;
Donnelly, Sheila .
IMMUNOBIOLOGY, 2015, 220 (02) :262-269
[2]   Secondary alveolar echinococcosis in lymphotoxin-α and tumour necrosis factor-α deficient mice:: exacerbation of Echinococcus multilocularis larval growth is associated with cellular changes in the periparasitic granuloma [J].
Amiot, F ;
Vuong, P ;
Defontaines, M ;
Pater, C ;
Dautry, F ;
Liance, M .
PARASITE IMMUNOLOGY, 1999, 21 (09) :475-483
[3]   Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology [J].
Ammann, Rudolf W. ;
Stumpe, Katrin D. M. ;
Grimm, Felix ;
Deplazes, Peter ;
Huber, Sabine ;
Bertogg, Kaja ;
Fischer, Dorothee R. ;
Muellhaupt, Beat .
PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (09)
[4]   Echinococcus multilocularis laminated-layer components and the E14t 14-3-3 recombinant protein decrease NO production by activated rat macrophages in vitro [J].
Andrade, MA ;
Siles-Lucas, M ;
Espinoza, E ;
Arellano, JLP ;
Gottstein, B ;
Muro, A .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 10 (03) :150-155
[5]   Successful intestinal Echinococcus multilocularis oncosphere invasion and subsequent hepatic metacestode establishment in resistant RccHan™:WIST rats after pharmacological immunosuppression [J].
Armua-Fernandez, Maria Teresa ;
Joekel, Deborah ;
Schweiger, Alexander ;
Eichenberger, Ramon Marc ;
Matsumoto, Jun ;
Deplazes, Peter .
PARASITOLOGY, 2016, 143 (10) :1252-1260
[6]  
Aydinli Bulent, 2008, Turkiye Parazitol Derg, V32, P371
[7]   Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby [J].
Barnes, T. S. ;
Hinds, L. A. ;
Jenkins, D. J. ;
Coleman, G. T. ;
Colebrook, A. L. ;
Kyngdon, C. T. ;
Gauci, C. G. ;
Lightowlers, M. W. .
PARASITOLOGY, 2009, 136 (04) :461-468
[8]   EFFECT OF IMMUNOSUPPRESSION ON SECONDARY ECHINOCOCCUS-MULTILOCULARIS INFECTIONS IN MICE [J].
BARON, RW ;
TANNER, CE .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 1976, 6 (01) :37-42
[9]   Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China [J].
Bartholomot, B ;
Vuitton, DA ;
Harraga, S ;
Shi, DZ ;
Giraudoux, P ;
Barnish, G ;
Wang, YH ;
Macpherson, CNL ;
Craig, PS .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 66 (01) :23-29
[10]   The role of transforming growth factor β in lung development and disease [J].
Bartram, U ;
Speer, CP .
CHEST, 2004, 125 (02) :754-765